Dwight A. Bellinger

5.9k total citations
81 papers, 4.7k citations indexed

About

Dwight A. Bellinger is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Dwight A. Bellinger has authored 81 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 30 papers in Genetics and 25 papers in Molecular Biology. Recurrent topics in Dwight A. Bellinger's work include Virus-based gene therapy research (26 papers), Platelet Disorders and Treatments (20 papers) and CAR-T cell therapy research (15 papers). Dwight A. Bellinger is often cited by papers focused on Virus-based gene therapy research (26 papers), Platelet Disorders and Treatments (20 papers) and CAR-T cell therapy research (15 papers). Dwight A. Bellinger collaborates with scholars based in United States, China and Denmark. Dwight A. Bellinger's co-authors include Timothy C. Nichols, Marjorie S. Read, Katherine A. High, Mark A. Kay, Kenneth M. Brinkhous, Elizabeth P. Merricks, Roland W. Herzog, Arthur R. Thompson, Thomas R. Griggs and Charles N. Landen and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Dwight A. Bellinger

75 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dwight A. Bellinger United States 35 2.6k 2.4k 1.2k 1.1k 432 81 4.7k
Paul E. Monahan United States 36 2.3k 0.9× 2.3k 1.0× 887 0.8× 1.3k 1.2× 380 0.9× 99 4.2k
Andréa Pavirani France 42 3.6k 1.4× 4.1k 1.7× 1.1k 0.9× 801 0.7× 344 0.8× 115 7.6k
Philip W. Zoltick United States 30 1.2k 0.4× 1.8k 0.8× 866 0.7× 170 0.2× 250 0.6× 69 3.9k
Felicia L. Graham United States 27 1.4k 0.5× 1.5k 0.6× 576 0.5× 195 0.2× 199 0.5× 43 3.2k
Bénédicte Dubois Belgium 30 560 0.2× 1.1k 0.5× 1.1k 0.9× 539 0.5× 216 0.5× 84 4.9k
Aaro Miettinen Finland 41 1.4k 0.5× 2.1k 0.9× 412 0.4× 313 0.3× 201 0.5× 122 6.1k
Françoise Selz France 20 1.5k 0.6× 1.7k 0.7× 743 0.6× 229 0.2× 116 0.3× 32 3.5k
Marco W. Schilham Netherlands 40 955 0.4× 1.2k 0.5× 1.4k 1.2× 621 0.6× 111 0.3× 99 5.3k
Andrew D. Leavitt United States 26 336 0.1× 1.3k 0.5× 342 0.3× 949 0.8× 347 0.8× 71 3.2k
Donna D. Strong United States 35 595 0.2× 1.8k 0.8× 422 0.4× 315 0.3× 185 0.4× 78 3.5k

Countries citing papers authored by Dwight A. Bellinger

Since Specialization
Citations

This map shows the geographic impact of Dwight A. Bellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dwight A. Bellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dwight A. Bellinger more than expected).

Fields of papers citing papers by Dwight A. Bellinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dwight A. Bellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dwight A. Bellinger. The network helps show where Dwight A. Bellinger may publish in the future.

Co-authorship network of co-authors of Dwight A. Bellinger

This figure shows the co-authorship network connecting the top 25 collaborators of Dwight A. Bellinger. A scholar is included among the top collaborators of Dwight A. Bellinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dwight A. Bellinger. Dwight A. Bellinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soto, Robert J., Elizabeth P. Merricks, Dwight A. Bellinger, Timothy C. Nichols, & Mark H. Schoenfisch. (2017). Influence of diabetes on the foreign body response to nitric oxide-releasing implants. Biomaterials. 157. 76–85. 27 indexed citations
2.
Maile, L.A., Walker H. Busby, Gang Xi, et al.. (2017). An anti-αVβ3 antibody inhibits coronary artery atherosclerosis in diabetic pigs. Atherosclerosis. 258. 40–50. 9 indexed citations
3.
Bellinger, Dwight A., et al.. (2015). Antioxidant Therapies for Ulcerative Dermatitis: A Potential Model for Skin Picking Disorder. PLoS ONE. 10(7). e0132092–e0132092. 14 indexed citations
4.
Nichols, Timothy C., Elizabeth P. Merricks, Dwight A. Bellinger, et al.. (2015). Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet. PLoS ONE. 10(7). e0132302–e0132302. 8 indexed citations
5.
Wang, Xiaojun, et al.. (2014). Targeted Disruption of LDLR Causes Hypercholesterolemia and Atherosclerosis in Yucatan Miniature Pigs. PLoS ONE. 9(4). e93457–e93457. 71 indexed citations
6.
Sherman, Alexandra, Alexander Schlachterman, Mario Cooper, et al.. (2014). Portal Vein Delivery of Viral Vectors for Gene Therapy for Hemophilia. Methods in molecular biology. 1114. 413–426. 11 indexed citations
7.
Nurden, Paquita, Alan T. Nurden, Timothy C. Nichols, et al.. (2013). Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A. Nature Communications. 4(1). 2773–2773. 93 indexed citations
8.
Sabatino, Denise E., Timothy C. Nichols, Elizabeth P. Merricks, et al.. (2011). Animal Models of Hemophilia. Progress in molecular biology and translational science. 105. 151–209. 50 indexed citations
9.
Haurigot, Virginia, Federico Mingozzi, George Buchlis, et al.. (2010). Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs. Molecular Therapy. 18(7). 1318–1329. 52 indexed citations
10.
Moy, Sheryl S., et al.. (2008). Effects of cage size and enrichment on reproductive performance and behavior in C57BL/6Tac mice. Lab Animal. 38(1). 24–34. 40 indexed citations
11.
Bellinger, Dwight A., et al.. (2006). Swine Models of Type 2 Diabetes Mellitus: Insulin Resistance, Glucose Tolerance, and Cardiovascular Complications. ILAR Journal. 47(3). 243–258. 141 indexed citations
12.
Sjöberg, Agneta, et al.. (2004). FISH mapping of the porcine vWF gene to chromosome 5q21 extends synteny homology with human Chromosome 12. Hereditas. 124(2). 199–202. 2 indexed citations
13.
Ehrhardt, Anja, Hui Xu, Aaron Dillow, et al.. (2003). A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia. Blood. 102(7). 2403–2411. 63 indexed citations
14.
Fischer, Thomas, Elizabeth P. Merricks, Dwight A. Bellinger, et al.. (2001). SPLENIC CLEARANCE MECHANISMS OF REHYDRATED, LYOPHILIZED PLATELETS. Artificial Cells Blood Substitutes and Biotechnology. 29(6). 439–451. 22 indexed citations
15.
Wang, Lili, Timothy C. Nichols, Marjorie S. Read, Dwight A. Bellinger, & Inder M. Verma. (2000). Sustained Expression of Therapeutic Level of Factor IX in Hemophilia B Dogs by AAV-Mediated Gene Therapy in Liver. Molecular Therapy. 1(2). 154–158. 148 indexed citations
16.
Snyder, Richard O., Carol H. Miao, Leonard Meuse, et al.. (1999). Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nature Medicine. 5(1). 64–70. 339 indexed citations
17.
Bellinger, Dwight A., J. Koudy Williams, Michael R. Adams, Éric Honoré, & Diane E. Bender. (1998). Oral Contraceptives and Hormone Replacement Therapy Do Not Increase the Incidence of Arterial Thrombosis in a Nonhuman Primate Model. Arteriosclerosis Thrombosis and Vascular Biology. 18(1). 92–99. 19 indexed citations
18.
Fang, B, Randy C. Eisensmith, Mark A. Kay, et al.. (1995). Gene Therapy for Hemophilia B: Host Immunosuppression Prolongs the Therapeutic Effect of Adenovirus-Mediated Factor IX Expression. Human Gene Therapy. 6(8). 1039–1044. 98 indexed citations
19.
Brinkhous, Kenneth M., Robert L. Reddick, Marjorie S. Read, et al.. (1991). Von Willebrand Factor and Animal Models: Contributions to Gene Therapy, Thrombotic Thrombocytopenic Purpura, and Coronary Artery Thrombosis. Mayo Clinic Proceedings. 66(7). 733–742. 32 indexed citations
20.
Bellinger, Dwight A., et al.. (1983). Rabies induced in a cat by high-egg-passage Flury strain vaccine. Journal of the American Veterinary Medical Association. 183(9). 997–998. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul E. Monahan Breakdown of academic impact, for papers by Andréa Pavirani Breakdown of academic impact, for papers by Philip W. Zoltick Breakdown of academic impact, for papers by Felicia L. Graham Breakdown of academic impact, for papers by Bénédicte Dubois Breakdown of academic impact, for papers by Aaro Miettinen Breakdown of academic impact, for papers by Françoise Selz Breakdown of academic impact, for papers by Marco W. Schilham Breakdown of academic impact, for papers by Andrew D. Leavitt Breakdown of academic impact, for papers by Donna D. Strong
Rankless by CCL
2026